At a glance
- Originator Vienna University
- Class Class I antiarrhythmics; Propiophenones; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 05 Feb 1998 No-Development-Reported for Arrhythmias in Austria (Unknown route)
- 10 Dec 1994 Preclinical development for Arrhythmias in Austria (Unknown route)